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Abstract
Acidithiobacillus ferrooxidans is an acidophilic chemolithotrophic bacterium that can grow in the presence of either a weak reductant,
Fe2 + , or reducing sulfur compounds that provide more energy for growth than Fe2 + . Here we first review the latest findings about the uphill
electron transfer pathway established in iron-grown A. ferrooxidans, which has been found to involve a bc1 complex. We then provide
evidence that this bc1 complex cannot function in the forward direction (exergonic reaction), even with an appropriate substrate. A search for
the sequence of the three redox subunits of the A. ferrooxidans bc1 complex (strain ATCC 19859) in the complete genome sequence of the A.
ferrooxidans ATCC 23270 strain showed the existence of two different bc1 complexes in A. ferrooxidans. Cytochrome b and Rieske protein
sequence comparisons allowed us to point out some sequence particularities of these proteins in A. ferrooxidans. Lastly, we discuss the
possible reasons for the existence of two different ‘‘classical’’ bc1 complexes and put forward some suggestions as to what role these putative
complexes may play in this acidophilic chemolithotrophic bacterium.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Acidithiobacillus ferrooxidans is an acidophilic chemo-
lithotrophic gram-negative bacterium, which is used in the
industrial extraction of copper and uranium from ores using
the microbial leaching technique [1]. The special feature of
the chemolithotrophs is their unique ability to use inorganic
compounds in redox reactions to provide energy for all the
processes required for cell growth and maintenance. A.
ferrooxidans derives this energy by oxidizing a number of
reducing sulfur species (Sj, S2 , S2O3
2 , SO3
2
, S4O6
2 )
or ferrous ions (Fe2 + ) under extremely acidic conditions,
with O2 as the oxidant [2–4]. When this bacterium grows
on Fe2 + , little energy is available as the result of the
oxidative reaction. However, the bacterium fixes its own
CO2, and Fe
2 + oxidation must therefore be coupled to the
reduction of NAD + (P) required for this fixation and other
anabolic processes. As the redox midpoint potential (Em) of
the couple Fe3 + /Fe2 + ( + 650 mV at pH 2) is much more
positive than that of the couple NAD(P) + /NAD(P)H
( 305 mV at pH 6.5, the cytoplasmic pH of A. ferroox-
idans [5]), the reduction of NAD(P) + from Fe2 + requires
energy. It has been suggested that an uphill electron transfer
established at the expense of the energy derived from the
oxidation of Fe2 + by oxygen may be involved in the
reduction of NAD(P) + from Fe2 + [6]. The electron transfer
chain from Fe2 + to O2 has been thought to involve a Fe
2 +-
cytochrome c oxido-reductase [7,8], rusticyanin [9–11],
several c-type cytochromes (the 14 kDa soluble cytochrome
c [12] and/or c4-type cytochromes [13,14,18], and the outer
membrane Cyc2 cytochrome [16], which is identical to the
46 kDa cytochrome c [15,18]), and a cytochrome c oxidase
[17]. In addition, a 30 kDa membrane-bound c type cyto-
chrome has been isolated and characterized from iron-grown
A. ferrooxidans [15,18]. In the A. ferrooxidans ATCC 23270
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genome, computer analysis was performed to identify 11
putative cytochromes c, four of which belong to the c4
cytochrome family [19]. However, the pathway between
Fe2 + and O2 has not yet been completely elucidated and
several different models have been proposed [14,16,20–22].
Elbehti et al. [18,23] provided evidence for the presence of a
bc1 complex in iron-grown A. ferrooxidans and its involve-
ment in the uphill electron transfer between reduced cyto-
chrome c and NAD + . When the bacterium grows on sulfur
compounds, the oxidative reaction provides more energy
than when it grows on iron. The midpoint potential of the
corresponding couples are sufficiently low for the bc1
complex to be able to function in the forward direction.
In this paper, we first review the latest data available on
the uphill electron transfer chain, and then report on the
existence of two bc1 complexes in A. ferrooxidans genome
and discuss their possible functional role in the electron
transfer reactions.
2. Characterization of the bc1 complex of the A.
ferrooxidans bacterium
Like the classical bc1 complexes, that of A. ferrooxidans
contains a cytochrome c1, a Rieske iron sulfur protein (ISP)
and a cytochrome b [18,24].
Studies on the optical spectral shifts induced by the
specific inhibitors of the bc1 complexes have provided
evidence for the existence of a dihemic cytochrome b in A.
ferrooxidans and have shown that antimycin A and HQNO
bind near heme bH [which is located on the cytoplasmic side
of the membrane (QN site at a near neutral pH)] and
stigmatellin near heme bL [which is located on the periplas-
mic side of the membrane (QP site at acidic pH)] [18].
EPR spectra of ascorbate-reduced membrane prepara-
tions of iron-grown A. ferrooxidans showed a derivative-
shaped gy signal characteristic of the so-called Rieske center
( gy= 1.90). The gx= 1.74 signal obtained at pH 7.4 was
broadened and shifted towards a lower magnetic field at pH
3.5 [18]. In all the bc1 complexes, the gx signal is sharp in
the presence of oxidized quinone, shifts towards higher
fields and broadens when ubiquinone becomes reduced. In
the b6f complexes, the gx trough was shown to broaden and
to shift towards lower fields in the presence of reduced
plastoquinone [34]. Thus, our results suggest that at pH 3.5,
the Q pool was at least partly reduced by the added
ascorbate (Em = 200 mV at pH 3.5), whereas it remained
oxidized at pH 7.4. These results agree with the fact that the
value of the normal midpoint potential of the quinone/quinol
couple increases by 60 mV/pH unit when the pH decreases,
giving a theoretical value of 320 mV for the Q/QH2 couple
at pH 3.5. The Rieske EPR gx signal was found to be
Fig. 1. Thermodynamic profile of the redox centers of the A. ferrooxidans bc1 complex when the value of the external pH is 7.4 (A) or 3.5 (B) compared with
profiles of typical bc1 (continuous boxes) and b6f complexes (dashed boxes) (C). Based on the data obtained on the c type cytochromes, it was not possible to
decide which of the two redox species at 150 and 485 mV (pH 7.4) and at 240 and 560 mV (pH 3.5) belongs to cytochrome c1 and which to cytochrome c 46
kDa (figure adapted from Ref. [18]).
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sensitive to the QP site inhibitors DBMIB, UHDBT and
stigmatellin in a different way from what has been observed
in the case of the bc1 and b6f complexes, and a response of
this kind has been observed so far only in Heliobacterium
chlorum [25].
The values of the midpoint potentials of the b and c type
hemes and that of the Rieske [2Fe–2S] cluster were
obtained from optical and EPR redox titrations carried out
on membrane preparations of iron-grown A. ferrooxidans
[18,26]. In Fig. 1, the thermodynamic profile of the redox
centers of the A. ferrooxidans bc1 complex is compared with
that of the typical bc1 and b6f complexes.
All in all, these results showed that the bc1 complex
expressed in iron-grown cells of A. ferrooxidans exhibited
some specific characteristics: (1) the midpoint potential of
the [2Fe–2S] cluster of the Rieske protein was 150 mV
higher than those typically measured in other bc1 com-
plexes; (2) at acidic external pH (the internal pH being near
neutrality), which corresponds to the physiological growth
conditions, the two hemes b both exhibited the same
midpoint potential (Em value of bL at pH 3.5 and Em value
of bH at pH 7.4 are both around 0 mV, Fig. 1A,B). In the
classical bc1 complexes, which function in the forward
direction under physiological conditions, the DEm between
the two hemes is about 100 mVat neutral pH, and the Em of
heme bL is lower than that of bH (Fig. 1C).
In addition, it is worth noting that the redox midpoint
potential of the Q/QH2 couple should be higher at the QP
site (about 320 mV, periplasmic acidic pH) than at the QN
site (about 80 mV, cytoplasmic neutral pH). The hypo-
thetical mechanism proposed for the reverse electron trans-
fer through the bc1 complex in A. ferrooxidans showed that
it might be facilitated by the specific characteristics of these
functional parameters (Em values of b hemes and Em value
of Q/QH2 at the P and N sites) in comparison with those in
the typical bc1 complexes (Ref. [18] and D. Lemesle-
Meunier et al., unpublished results).
3. Function of the bc1 complex in iron-grown cells of A.
ferrooxidans
3.1. The bc1 complex expressed when the cells are grown on
iron functions in reverse at physiological pH
In A. ferrooxidans, the energy-dependent reversal of the
electron transfer process involved in the reduction of pyridine
nucleotides is of considerable physiological importance,
since the CO2 fixation depends on this process. Given a
sufficiently high proton motive force, electrons on an inter-
mediate carrier will be pushed back up the chain and NAD +
will become reduced. In A. ferrooxidans, the most recent
model proposed for the exergonic electron transfer pathway
from Fe2 + to O2 is as follows: Fe
2 + ! cytochrome Cyc2
(outer membrane localization)! rusticyanin (periplasmic
localization)! cytochrome c4 (bound to the periplasmic side
of the inner membrane)! cytochrome c oxidase (inner
membrane localization) [16,20]. Since the classical bc1 com-
plexes exhibit a thermodynamically favorable quinol-cyto-
chrome c reductase activity, the electron donor for the reverse
reaction has to be a ferrocytochrome c. In order to determine
whether electrons arising from ferrocytochrome c might take
a pathway other than via cytochrome oxidase, and in order to
characterize this pathway, the oxygen consumption and
cytochrome c oxidation were monitored after adding external
ferrocytochrome c to a suspension ofA. ferrooxidans (BRGM
strain) spheroplasts at acidic pH. The sensitivity of these two
reactions to CCCP, DNP, oligomycin, ATP and to the inhib-
itors of the bc1 and NDH-1 complexes was measured. The
results indicate the existence of an energy-dependent electron
transfer pathway from ferrocytochrome c to NAD + , which
proceeds through a bc1 and an NDH-1 complex and is driven
by a proton motive force resulting at least partly from ATP
hydrolysis [23]. A model in which the ATP/ADP ratio plays a
central role has been proposed to tentatively explain how the
balance of reducing equivalents between the endergonic and
exergonic pathways is controlled in vivo [23].
3.2. The bc1 complex expressed when the cells grow on iron
cannot function in the forward direction at physiological pH
A. ferrooxidans can grow on Fe2 + and/or sulfur com-
pounds at acidic pH. The midpoint potentials of these
various sulfur compounds are sufficiently low to potentially
reduce the bc1 complex and thus allowing it to function in
the forward mode. In our experiments, the A. ferrooxidans
(BRGM strain) cells grown on iron exhibited a thiosulfate–
quinone reductase activity that was inhibited by HQNO, an
inhibitor of quinol oxidase and quinol reductase enzymes
(Table 1). They also exhibited a thiosulfate!O2 activity
not inhibited by a low concentration of KCN (0.5 mM)
(which was found to totally inhibit the exergonic Fe2 + !O2
pathway [23]) but inhibited by a high concentration
(5 mM) of this inhibitor (concentration known to inhibit
the quinol type oxidases). This thiosulfate!O2 activity
was not sensitive to the specific bc1 complex inhibitors
antimycin and myxothiazol, or only very slightly at a high
concentration (known to partly inhibit the quinol oxidase
enzymes) (Table 1). This indicates that the hydroquinone
formed at the thiosulfate quinone reductase step can give
electrons to neither the bc1 complex nor the aa3 cytochrome
oxidase, but only to a quinol oxidase. These results suggest
that the bc1 complex expressed when the cells are grown on
iron does not function in the forward direction at the
physiological pH, even with a thermodynamically appro-
priate substrate such as thiosulfate. In agreement with these
experimental results, the thermodynamic profile of the A.
ferrooxidans bc1 complex at pH 3.5 compared to that of the
classical bc1 complexes (Fig. 1) shows that it would be more
difficult for the bc1 complex of this bacterium than for the
classical bc complexes to function in the forward direction.
Indeed, a feature inherent of the Q cycle is that the electron
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transfer from ubiquinol to, on the one hand, the [2Fe–2S]
cluster, and, on the other hand, the heme bL, are two
mechanistically coupled reactions so that the energetically
favorable oxidation of ubiquinol by the Rieske cluster drive
the energetically unfavorable reduction of heme bL. Thus,
the exergonicity of the first reaction with regards to the
endergonicity of the second reaction is important to allow
the system to be kinetically competent. Assuming that, at the
start of the reaction, the Q/QH2 couple is poised 90%
reduced, and the Rieske center and the heme bL at 99%
oxidized, the Eh values of these compounds calculated for A.
ferrooxidans and for the classical bc complexes (Em values
from Fig. 1) show that, for a DEh value of the exergonic
reaction [Eh (Q/QH2)Eh (FeS)] equal to  310 mV for A.
ferrooxidans and for the classical bc1 complexes ( 370 mV
for the b6f), the energy necessary to reduce heme bL is
important for A. ferrooxidans [Eh (Q/QH2)Eh (bL)= + 170
mV], whereas in the same conditions, reduction of heme bL
is easier for the classical bc1 and b6f complexes [Eh (Q/
QH2)Eh (bL) = 20 and + 80 mV, respectively). This
shows that it is thermodynamically more difficult (although
not theoretically impossible) for the forward electron trans-
fer to occur in A. ferrooxidans bc1 complex than in other bc
complexes. For the Q cycle to be able to function in the
forward direction at acidic pH, it can therefore be suggested
that the values of the midpoint potential of the Rieske
protein and/or those of the b hemes of the complex involved
will have to be higher than the measured value given above.
4. The acidophilic chemolithotrophic bacterium A.
ferrooxidans contains two bc1 complexes
Levican et al. [27] recently identified a pet operon that
potentially encodes the three redox subunits of a bc1
complex in A. ferrooxidans ATCC 19859 and ATCC
33020 strains. This pet operon also encodes a dihemic
cytochrome c4 and a SdrA subunit corresponding to a short
polypeptide belonging to the family of ribitol/glucose
oxido-reductase. The corresponding genes occur in the
following order: cycA (cytochrome c4), sdrA (ribitol/glucose
oxido-reductase), petA (ISP), petB (cytochrome b) and petC
(cytochrome c1).
In a search for the sequences of the three redox subunits
of the bc1 complex of the A. ferrooxidans ATCC 19859
strain (Genbank AC: AF220499) in the complete (but not
annotated) genome sequence of A. ferrooxidans ATCC
23270 strain (TIGR/USA), genes encoding for two dihemic
b-type cytochromes (b1 and b2), two c1-type cytochromes,
(c1
1 and c1
2), and two iron-sulfur Rieske proteins (ISP1,
ISP2) were identified. A search was also performed using
the homologous sequences from Saccharomyces cerevisiae
and B. taurus and similar results were obtained, with lower
rates of identity. The genes coding on the one hand for ISP1,
b1, c1
1 and on the other hand for ISP2, b2, c1
2, are clustered
together in the same order: petA (ISP), petB (cyt b), petC
(cyt c1), at two different loci (locus 1 and locus 2). The
second pet locus was found to be also present in A.
ferrooxidans ATCC 33020 and ATCC 19859 strains (P.
Bruscella, G., Levican, D. Holmes and V. Bonnefoy, unpub-
lished results) and is now under investigation.
Therefore, the genome of the acidophilic chemolithotro-
phic A. ferrooxidans bacterium encodes two bc1 complexes.
5. Cytochrome b and Rieske protein sequence
comparisons
It seemed to be worth comparing the cytochrome b and
Rieske protein sequences of A. ferrooxidans with those of
other acidophilic and/or chemolithotrophic proteobacteria.
Besides Nitrosomonas europea, which is a neutrophilic
chemolithotrophic microorganism, there exist no acidophilic
and/or chemolithotrophic proteobacteria for which the entire
sequence of the genome is known. A search in the data bank
for the sequences of the three redox subunits of the two bc1
complexes of A. ferrooxidans ATCC 23270 strain (as well
as that of the S. cerevisiae bc1 complex) in the complete
genome sequence of N. europea (JGI/USA) showed that this
bacterium contains only one bc1 complex.
5.1. Cytochrome b
Fig. 2A shows the alignment of the cytochrome b
sequences of the bc1 complexes of A. ferrooxidans ATCC
23270 strain, N. europea and S. cerevisiae. Upon examining
Table 1
Action of inhibitors on the thiosulfate!O2 and thiosulfate–quinone reductase activities in A. ferrooxidans (BRGM strain) cells grown on iron
Activities Without inhibitor Percent (%) inhibition with
(nmol/min/mg)
HQNO Antimycin Myxothiazol KCN Azide
Thiosulfate!O2a 125 100 10 8 70 100
Thiosulfate!Q1b 30 100 0 0 0 0
Inhibitor final concentrations: HQNO 10 AM, antimycin 15 AM (390 nmol/nmol cyt b), myxothiazol 7 AM (182 nmol/nmol cyt b), KCN 5 mM and azide 1
mM.
a Thiosulfate!O2 activity was measured polarographically at 25 jC in 20 mM h alanine/H2SO4 buffer (pH 3.5) with a Clark oxygen electrode.
b The reduction of quinone Q1 (80 AM) by thiosulfate (6 mM) was monitored using the dual wavelength-stirred reaction procedure at 278/325 nm with an
Aminco DW2A spectrophotometer.
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Fig. 2. Sequence alignments of cytochrome b (A) and Rieske protein (B) of bc1 complexes. The -P-E272-W-Y- sequence of cytochrome b (A), the two boxes
-C129-X-H-L- and -C148-P-C-H-, which contain the [2Fe–2S] cluster ligands, and the -P165-A-P- sequence of the Rieske protein (B) are shaded in gray. Stars
indicate some of the totally conserved residues like the four histidine (H82, H96, H183, H197) ligands of the two cytochrome b hemes (A) and C134 involved
in the disulfide bridge with C150 in the Rieske protein (B). Arrows indicate amino acids discussed in the text. A. ferro1: A. ferrooxidans locus 1; A. ferro2: A.
ferrooxidans locus 2; S. cerev.: S. cerevisiae; N. europ.: Nitrosomonas europea. The alignment was performed using the program CLUSTAL W.
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this alignment in parallel with that of Berry et al. [28],
taking S. cerevisiae as the reference, it was observed that the
two cytochrome b of A. ferrooxidans exhibit some sequence
particularities:
(1) They contain 14 rather than 13 amino acids between
the heme-ligating histidine residues in helix D (H183 and
H197, yeast numbering). This feature, which was initially
thought to be characteristic of the cytochrome b6 from the
b6f complexes, was later also found to occur in bc1 com-
plexes in the h, g and q subdivisions of proteobacteria. N.
europea, which belongs to the h subdivision of proteobac-
teria, also exhibits this characteristic (Fig. 2A).
(2) Another particularity concerns the highly conserved -
PEWY- region between helices E and F, which was pro-
posed to play an important functional role in the deproto-
nation of the quinol at the Qp site [29]. The crystallographic
data obtained so far on various eukaryotic bc1 complexes
show the possible formation of an H-bond between quinol
(assimilated to the inhibitor stigmatellin) and H131 of the
Rieske ISP on the one hand, and between quinol and E272
of cytochrome b on the other hand (yeast numbering, Fig.
2), when ISP is docked on cytochrome b at the P side.
Moreover, structural data have shown that the side chain of
E272 projects into the QP pocket in the stigmatellin struc-
ture, and out of the pocket in the MOA-stilbene and
myxothiazol structures. This finding led Crofts et al. [29]
to propose a possible molecular mechanism for quinol oxi-
dation at center P. However, the glutamic acid of the -PEWY-
sequence of the ef loop is not completely conserved (Fig. 2A
and alignments in Refs. [28,30]). Some species have the
more conservative -PDWY- sequence but some others do
not have an acidic residue at position 272. In A. ferroox-
idans, this sequence is -PPWY- for the two cytochromes b.
Proline was also found to be present in the analogous bc1
complex of the hyperthermophilic aerobic craenarchae Aero-
pyrum pernix and that of the acidophilic obligate aerobic
Sulfolobus acidocaldarius [28,30]. In other bacteria such as
N. europea, V has been found instead of E at position 272
(Fig. 2A). It is worth noting that in all the species that have
V272 or P272 instead of E272, there is an E in various
positions in the ef loop [E256 in A. ferrooxidans and N.
europea (Fig. 2A); E267/E258/E253 in Pseudomonas and
Vibrio, E253 in Neisseria, Chromatium and Bordetella (see
alignment Ref. [28]) yeast numbering). In the crystal struc-
ture of the yeast bc1 complex [31], all these positions are
too far from the nearest atom of the stigmatellin polar head
(more than 6 A˚) to form an H-bond. However, in these
species, two or more amino acids are inserted in various
positions of the ef loop (Fig. 2A and alignment Ref. [28]),
which may affect its positioning and therefore that of the
putative glutamic acid.
(3) Another point is the presence of the negatively
charged residue D in position 84, between H82 and H96
of helix B (ligands of hemes bL and bH, respectively). A
negatively charged amino acid in this position is found to
occur only in the two cytochromes b of A. ferrooxidans (Fig.
2A and Refs. [28,30]). It should be noted that cytochrome b
from Aquifex aeolicus and cytochrome b6 from spinach and
Synechocystis contain the positively charged amino acid R
in position 84 (cyt b) and in the nearby position 83 (cyt b6),
respectively.
(4) Among the highly conserved amino acids, only that
in position 79, which is generally R, differs between the two
cytochrome b sequences of A. ferrooxidans: R is conserved
in b1 but Q is found in b2 (Fig. 2A). This position was found
to be at a distance of 2.9 A˚ from the closest atom of the
propionate of heme bL. The presence of an uncharged
glutamine instead of a positively charged arginine in this
position may affect the redox midpoint potential of heme bL
and may partly explain the possible functional differences
between the two bc1 complexes present in A. ferrooxidans
(see Section 6).
5.2. Rieske protein
The alignment in Fig. 2B shows that the two boxes -C129-
X-H131-L132- (yeast numbering) and -C148-X-C-H151-,
which contain the four ligands of the [2Fe–2S] cluster,
and the two cysteines (C134 and C150) that are involved
in the disulfide bridge, as well as the -P165-A-P- motif of the
so-called Pro-loop are all conserved in the two Rieske
sequences of A. ferrooxidans. The -S153-X-Y155- motif,
which was found to be conserved in organisms that use high
potential quinones, was also found to be conserved in the
two Rieske proteins of A. ferrooxidans. An important point
concerns the substitution of the conserved G133 of the motif
-C129-X-H-L-G133-C134- by C in the two Rieske proteins of
A. ferrooxidans. In S. cerevisiae, a mutation in this position
has been found to modify the Em of the [2Fe–2S] cluster
[32]. May this substitution partly responsible for the high Em
value of the [2Fe–2S] cluster of the Rieske protein recorded
in A. ferrooxidans?
6. Why are there two bc1 complexes in A. ferrooxidans?
A. ferrooxidans is the sole organism known so far to
contain two ‘‘classical’’ bc1 complexes (i.e. having con-
served a c1 type cytochrome). Is this feature linked to the
fact that this chemolithotrophic bacterium can grow either
in the sole presence of Fe2 + , a weak reductant, or in the
presence of various sulfur compounds that are relatively
strong reductants? We have shown that the bc1 complex
synthesized when the cells grow on iron cannot function in
the forward direction, even with a thermodynamically
appropriate substrate as thiosulfate that leads to the for-
mation of hydroquinone. It has been suggested (but not
demonstrated) that in the case of sulfur-grown cells, sulfur
oxidation may involve a bc1 complex functioning in the
forward direction [33]. Might each of these two bc1 com-
plexes be specifically involved in either reverse functioning
(iron-grown cells) or forward functioning (sulfur com-
G. Brasseur et al. / Biochimica et Biophysica Acta 1555 (2002) 37–4342
pounds-grown cells)? Experiments are now in progress to
test this hypothesis.
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